Future Science Group
Browse

Portuguese translation - Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a patient and caregiver perspective and plain language summary of the ARASENS trial

Download all (6.35 MB)
Version 2 2023-03-15, 12:50
Version 1 2023-02-24, 08:57
online resource
posted on 2023-03-15, 12:50 authored by Matthew R. Smith, Maha Hussain Moalwi, Fred Saad, Karim Fizazi, Cora N Sternberg, David Crawford, Jan Manarite, David Muslin, Thomas Farrington, Bertrand Tombal

Portuguese translation of Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a patient and caregiver perspective and plain language summary of the ARASENS study 

Funding

Bayer, (Grant / Award Number: )

History

Usage metrics

    Future Oncology

    Categories

    Keywords

    metastatic hormone-sensitive prostate cancerOverall survivalSafetyDrug developmentNovel therapyUrological/prostateDarolutamidelay summaryPlain language summary

    Licence

    CC BY-NC-ND 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC